That said, being told you don't qualify for a trial you were hoping to join is genuinely disappointing, and understanding why the exclusion exists doesn't make it less frustrating. What it does is point you toward your next move.
Why eligibility criteria exist at all
Clinical trials are designed to answer a specific research question about a specific population. If you include people who don't match that population, their different responses contaminate the data and make it harder to tell whether the treatment worked. This isn't about being selective for its own sake — it's about generating results that regulatory agencies can actually use to evaluate the treatment.
Safety is the other driver. Some exclusions exist because certain medications, conditions, or health factors are known to interact badly with the investigational treatment. Excluding those participants isn't a judgment; it's risk management.
The most common reasons people are excluded
Prior treatment history. Many trials require that you haven't received certain prior treatments, or that you have received them. An oncology trial might require that participants have already tried two prior lines of therapy — meaning you qualify only if your cancer has progressed through earlier treatments.
Concurrent medications. Some drugs interact with investigational compounds in ways that either create safety risks or confound the data. Common culprits are immunosuppressants, certain anticoagulants, CYP3A4 inhibitors, and drugs with narrow therapeutic windows. If you're on a medication that appears in the exclusion criteria, ask whether there's a washout option — a period where you stop the medication before enrollment.
Organ function thresholds. Trials typically require minimum liver, kidney, and bone marrow function. These organs process and clear the investigational compound; impaired function raises the risk of toxic accumulation. If your function is borderline, ask whether a re-test closer to the screening visit is possible — function can fluctuate.
Comorbidities. Active infections, recent cardiac events, autoimmune conditions, and pregnancy are common exclusions. Some of these are temporary — if you have an active infection, you may qualify once it's resolved.
Geographic distance. Many trials require that participants live within a certain distance of the study site, or are able to attend visits at a specified frequency. This is practical, not medical.
When exclusion is worth challenging
Not every exclusion is rigid. Protocol deviations can be submitted to the IRB in some cases; the investigator may request a waiver for specific criteria if there's a strong clinical rationale. This is not common, and it's not something you should expect. But if you have a very strong clinical case — your physician believes you'd benefit and the exclusion criterion is a minor or borderline one — it's worth asking the investigator whether they've ever requested a waiver for that criterion.
Your next step after exclusion
Ask the study team to specify exactly which criterion excluded you. This isn't always volunteered, but you're entitled to know. With that information, you can:
Search for trials with less restrictive criteria for that specific factor. Trials vary significantly in how strictly they define eligibility — a Phase 2 trial at an academic medical center may be more flexible than a tightly controlled Phase 3 industry study.
Talk to your own physician about whether any of the excluding factors are modifiable — stopping a medication, treating a concurrent condition, waiting for a temporary exclusion to resolve.
Ask the study coordinator whether any related trials are open that might have different eligibility parameters. Sponsors often run multiple concurrent studies; the team may know of alternatives.